Association of the PPARγ2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia

Genetics and Molecular Research

Volumn 9, Issue 3, 2010, Pages 1312-1320

  Gao, L ^a   Wang, L ^a   Yun, H ^b   Su, L ^a   Su, X ^a  

^a INNER MONGOLIA MEDICAL COLLEGE   (China)

^b Inner Mongolia International Travel Health Care Center   (China)

Author keywords

Inner Mongolia; Metabolic lipid disorders; Polymorphism; PPAR 2 Pro12Ala; Primary hypertension

Indexed keywords

ALANINE; CHOLESTEROL; CYTOSINE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; TRIACYLGLYCEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONGOLIA; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SYSTOLIC BLOOD PRESSURE; AGAR GEL ELECTROPHORESIS; ASIAN; CASE CONTROL STUDY; CHINA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CHINA; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS, AGAR GEL; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LIPID METABOLISM DISORDERS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PPAR GAMMA; YOUNG ADULT;

EID: 77954398507     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol9-3gmr833     Document Type: Article

References (22)

1. Ahmed W, Ziouzenkova O, Brown J, Devchand P, et al. (2007). PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J. Intern. Med. 262: 184-198.
2. Buzzetti R, Petrone A, Caiazzo AM, Alemanno I, et al. (2005). PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr. Res. 57: 138-140.
3. Douglas JA, Erdos MR, Watanabe RM, Braun A, et al. (2001). The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes 50: 886-890.
4. Ereqat S, Nasereddin A, Azmi K, Abdeen Z, et al. (2009). Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res. 2009: 874126.
5. Gouni-Berthold I, Giannakidou E, Muller-Wieland D, Faust M, et al. (2005). Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. J. Hypertens. 23: 301-308.
6. Greene ME, Blumberg B, McBride OW, Yi HF, et al. (1995). Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 4: 281-299.
7. Hasstedt SJ, Ren QF, Teng K and Elbein SC (2001). Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J. Clin. Endocrinol. Metab. 86: 536-541.
8. He W (2009). PPARgamma2 polymorphism and human health. PPAR. Res. 2009: 849538.
9. Horiki M, Ikegami H, Fujisawa T, Kawabata Y, et al. (2004). Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases. Diabetes Res. Clin. Pract. 66 (Suppl 1): S63-S67.
10. Mirzaei H, Akrami SM, Golmohammadi T, Doosti M, et al. (2009). Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects. Metab. Syndr. Relat. Disord. 7: 453-458.
11. Ostgren CJ, Lindblad U, Melander O, Melander A, et al. (2003). Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg Hypertension and Diabetes Project. J. Hypertens. 21: 1657-1662.
12. Pinterova D, Cerna M, Kolostova K, Novota P, et al. (2004). The frequency of alleles of the Pro12Ala polymorphism in PPARgamma2 is different between healthy controls and patients with type 2 diabetes. Folia Biol. 50: 153-156.
13. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A and Alamo-Santana F (2003). Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension. J. Hypertens. 21: 1649-1655.
14. Sookoian S, Garcia SI, Porto PI, Dieuzeide G, et al. (2005). Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J. Mol. Endocrinol. 35: 373-380.
15. Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, et al. (2006). Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes. J. Hum. Hypertens. 20: 684-692.
16. Swarbrick MM, Chapman CM, McQuillan BM, Hung J, et al. (2001). A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur. J. Endocrinol. 144: 277-282.
17. Tai ES, Corella D, Deurenberg-Yap M, Adiconis X, et al. (2004). Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J. Lipid Res. 45: 674-685.
18. Tamori Y, Masugi J, Nishino N and Kasuga M (2002). Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045-2055.
19. Tavares V, Hirata RD, Rodrigues AC, Monte O, et al. (2005). Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Diabetes Obes. Metab. 7: 605-611.
20. Vanden Heuvel JP (2007). The PPAR resource page. Biochim. Biophys. Acta 1771: 1108-1112.
21. Yliharsila H, Eriksson JG, Forsen T, Laakso M, et al. (2004). Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication. J. Hypertens. 22: 1283-1287.
22. Zietz B, Barth N, Spiegel D, Schmitz G, et al. (2002). Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients. Exp. Clin. Endocrinol. Diabetes 110: 60-66.